Skip to content

Recurrence and Prognosis Prediction Model for Gastric Cancer

Artificial Deep Learning-Based Model for Predicting Postoperative Recurrence in Gastric Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07243847
Enrollment
5000
Registered
2025-11-24
Start date
2000-01-01
Completion date
2025-11-01
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer (GC)

Brief summary

This study, utilizing a large-scale multicenter Eastern database, has established a Deep Learning-based predictive model for recurrence following gastric cancer surgery, which demonstrates robust discriminatory power for early recurrence. Furthermore, the individualized recurrence probability generated by this model can predict long-term postoperative prognosis and effectively stratify patients based on risk, thereby guiding personalized treatment choices. This individualized risk probability is also applicable to both adjuvant chemotherapy and neoadjuvant chemotherapy populations, offering valuable support for precision treatment in gastric cancer.

Interventions

OTHERsurgery and/or chemo

Deep learning model

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Pathologically confirmed gastric adenocarcinoma; No distant metastases confirmed by preoperative examinations such as chest X-ray, abdominal ultrasonography, and upper abdominal computed tomography; Achievement of R0 resection.

Exclusion criteria

Presence of distant metastases detected preoperatively or intraoperatively; Prior neoadjuvant chemotherapy or radiotherapy; Incomplete general clinical data.

Design outcomes

Primary

MeasureTime frame
recurrence3 year after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026